Země: Irsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
ACTINOBACILLUS PLEUROPNEUMONIAE STRAIN NT3, ACTINOBACILLUS PLEURPNEUMONIAE STRAIN SZII, ACTINOBACILLUS PLEUROPNEUMONIAE STRAIN PO, ACTINOBACILLUS PLEUROPNEUMONIAE STRAIN U3, ACTINOBACILLUS PLEUROPNEUMONIAE STRAIN B4
Ceva Santé Animale
QI09AB07
ACTINOBACILLUS PLEUROPNEUMONIAE STRAIN NT3, ACTINOBACILLUS PLEURPNEUMONIAE STRAIN SZII, ACTINOBACILLUS PLEUROPNEUMONIAE STRAIN P
Unknown
Suspension for Injection
POM(E)
Porcine
Actinobacillus/Haemophilus vaccine
Immunological - Inactivated vaccine
Authorised
2015-10-23
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Coglapix suspension for injection for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One dose (2 ml) contains: ACTIVE SUBSTANCES: _Actinobacillus pleuropneumoniae _serotype 1 (strain NT3) and _Actinobacillus pleuropneumoniae _serotype 2 (strains PO, U3, B4, SZ II) expressing ApxI toxoid min. 28.9 ELISA unit / ml*, ApxII toxoid min. 16.7 ELISA unit / ml and ApxIII toxoid min. 6.8 ELISA unit / ml * Elisa unit / ml calculated serological titre in sera of immunised rabbits ADJUVANT: Aluminium hydroxide gel (as Al 3+ ) 4.85 mg EXCIPIENTS: Thiomersal max 0.22 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Suspension for injection Greyish-white, opaque liquid. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of pigs as an aid to control pleuropneumonia caused by _Actinobacillus pleuropneumoniae_ serotypes 1 and 2, by reducing the clinical signs and lung lesions associated with the disease. Onset of immunity: 21 days following second vaccination. Duration of immunity: 16 weeks following second vaccination. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES No information is available on the efficacy of the vaccine in animals with maternally derived antibodies. However, these antibodies are usually not present in piglets at the age of vaccination. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 23/10/2015_ _CRN 7017683_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Administer to healthy animals only. Special precautions to be taken by the person administ Přečtěte si celý dokument